Trials / Completed
CompletedNCT00510458
LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study
LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study - An Open Label, Prospective, Post-market, Multi-center Clinical Evaluation of the LFIT™ Anatomic CoCr Femoral Heads With X3® Inserts
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Stryker Orthopaedics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Total hip replacement surgery is considered to be a very successful surgical procedure for the treatment of degenerative joint disease. The purpose of the study is to evaluate a large size (36mm, 40mm or 44mm) femoral (hip) head called the LFIT™ Anatomic CoCr Femoral Head (Low Friction Ion Treatment). The large size femoral heads will be used with the Trident® X3® polyethylene (plastic) inserts and will be compared with a historical control. Study Hypothesis: The linear wear rate for hips implanted with the LFIT™ Anatomic CoCr Femoral Head is no worse than 0.08 mm wear per year at 5 years post-surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LFIT™ Femoral Heads With X3® Insert | LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2007-08-02
- Last updated
- 2018-03-12
- Results posted
- 2018-03-12
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00510458. Inclusion in this directory is not an endorsement.